4//SEC Filing
Drugs Made In America Acquisition II LLC 4
Accession 0001213900-25-094430
CIK 0002040475other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 10:37 AM ET
Size
11.1 KB
Accession
0001213900-25-094430
Insider Transaction Report
Form 4
Transactions
- Other
Ordinary shares
2025-09-26−400,000→ 14,675,000 total - Sale
Ordinary shares
2025-09-26−7,966,667→ 6,708,333 total - Purchase
Ordinary shares
2025-09-26+700,000→ 15,075,000 total - Purchase
Rights to receive ordinary shares
2025-09-26+700,000→ 700,000 total→ Ordinary shares (700,000 underlying)
Footnotes (4)
- [F1]Reflects 700,000 private units acquired by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $7,000,000.
- [F2]As of the Transaction Date, the reporting person transferred an aggregate of 400,000 ordinary shares to certain of the Issuer's officers and directors for no consideration.
- [F3]As of the Transaction Date, pursuant to share transfer agreements, the reporting person transferred an aggregate of 7,966,667 ordinary shares to a number of accredited investors for consideration ranging from no consideration to $1.50 per share.
- [F4]The rights convert automatically into ordinary shares at the completion of the Issuer's initial business combination.
Documents
Issuer
Drugs Made In America Acquisition II Corp.
CIK 0002040475
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002088432
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 10:37 AM ET
- Size
- 11.1 KB